TNPSC Thervupettagam

Oral Iron Treatment for Kids

December 26 , 2025 14 hrs 0 min 8 0
  • The US FDA has now approved Accrufer, a prescription oral medicine, for children aged 10 years and older with iron deficiency.
  • This offers a new, non-invasive treatment option that fits better into daily life.
  • Iron deficiency is the most common cause of anaemia.
  • This can result in persistent fatigue, reduced concentration, delayed growth, and poorer academic performance.
  • Until now, Accrufer was approved only for adults, starting in 2019.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories